Dr. Martin Yaffe
Ph.D., Senior Advisor, Member of the Order of Canada
Dr. Martin Yaffe is a senior scientist in physical sciences at the Odette Cancer Research Program at the Sunnybrook Research Institute in Toronto, Canada. Dr. Yaffe was a member of the team that drove the development of digital mammography.
His current work is focused on the development, improvement and optimization of breast cancer imaging techniques for screening and diagnosis, breast tomosynthesis, image quality assessment, breast density, breast cancer risk, biomarker imaging research including the development of new techniques for 3D pathology.
Dr. Karen Lindfors
M.D., MPH, FACR, Senior Advisor
Dr. Lindfors is a leading expert in the field of breast cancer screening and breast imaging and diagnostics, having specialized in cancer radiology and breast imaging and diagnostic radiology for more than 30 years. She is highly published and a leading advocate for women’s health who works locally and nationally to promote patient and healthcare professional education for early detection of breast cancer.
Dr. Lindfors has been the lead clinical researcher in developing new methods to screen for breast cancer, including dedicated breast CT developed at UC Davis and breast tomosynthesis.
Dr. Norbert Pelc
D.Sc., Senior Development and Technology Advisor
Dr. Pelc is a professor of bioengineering and radiology at Stanford University. Prior to joining the Stanford faculty in 1990, he was the senior physicist and manager of the applied sciences laboratory at GE Medical Systems where he developed technology for all medical imaging modalities.
His primary research interests are in the physics, engineering, and the mathematics of diagnostic imaging. His current work is focused on methods to improve information content, image quality and the reduction of radiation dose in computed tomography (CT) examinations.
Dr. Craig Shimasaki
Ph.D., MBA, Medical Device Business Consultant
Dr. Shimasaki is a scientist, businessperson, author and entrepreneur. Having co-founded three biotechnology companies, his mission has been to bring medically needed products from research, clinical testing, and regulatory approval to the public so that more patients can benefit from important new advances.
Over the last 35 years, his focus has been on the development of diagnostic and therapeutic products where he has worked with the FDA, conducted clinical trials, manufactured products, and helped to develop businesses. He has brought five products through the FDA 510(k) approval process and he has served in various roles at several companies, from director of project planning, vice president of research and development, chief operating officer, and chief executive officer.
M. Eng, Advisor
Mr. Burkett holds a Master’s Degree in Mechanical and Aeronautical Engineering and has spent the last 15 years working at UC Davis. He is credited for his crucial role in the detailed design and the mechanical and hardware development of breast CT, which included building and maintaining four successive breast CT imaging system models, each incorporating efficiencies and new cutting-edge technological advancements as they became available.
Dr. Craig Abbey
Dr. Abbey has served as a Scientific Reviewer for the FDA where he sat on independent review panels to evaluate reader studies proposed by companies seeking FDA approval of medical imaging devices including Hologic’s Digital Breast Tomosynthesis
Mr. Tokman specializes in creating and commercializing new technology businesses in the healthcare industry. His extensive experience includes leading several global business units within GE Healthcare where he led the creation, commercialization and growth of several new global medical imaging businesses, including PET/CT and Molecular Imaging as well as growing more established modalities such as X-Ray and Mammography.
Dr. Jeff Siewerdsen
Dr. Siewerdsen is a Professor and Vice-Chair in the Department of Biomedical Engineering at Johns Hopkins University in Baltimore, with appointments in Radiology, Neurosurgery, and Computer Science. His research is focused on new medical imaging technologies and algorithms, including CT and cone-beam CT (CBCT), image reconstruction and registration, and the physics of image quality.
Dr. Tao Wu
Dr. Tao Wu worked on the development of the world's first DBT prototype and proved the technical and clinical advantages through clinical studies. He joined Hologic as a principal medical physicist to develop commercial DBT and FFDM products. Later he was assigned by Hologic to promote DBT in the Asia Pacific region and manage operations in China. After leaving Hologic, Dr. Wu founded DART Imaging in China. His extensive development, manufacturing, and commercialization experience will further strengthen Izotropic's efforts to supersede these established technologies with IzoView Breast CT.